Sign in
WithdrawnNo phase

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Key facts

Who runs it
University of Oklahoma
Trial code
Status
Withdrawn
Started
Jun 2025
Ended
4 Jun 2025
Type of study
Interventional
Treatments tested
  • Ecologic Momentary Assessment (EMA)
Record updated
3 February 2026
Why it stopped
Study withdrawn due to lack of accrual.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age 18 years and older
  • Written informed consent and any locally-required authorization obtained from the patients prior to performing any protocol-related procedures, including screening evaluations
  • Pathologically (histologically or cytologically) proven diagnosis of cancer of the head and neck (nasopharynx, oral cavity, oropharynx, hypopharynx, larynx, or unknown primary) or Gynecologic cancers (cervical and endometrial)
  • Locally recurrent or metastatic HNC or Gyn cancer not deemed amenable to curative-intent salvage therapy, in whom at least six months have passed since their prior RT, if received
  • Must have evaluable lesion per RECIST v1.1
  • Patients agree to provide their smoking history prior to registration
  • ECOG performance status of 0-2

Who cannot take part

  • Prior radiotherapy to the region of the study cancer within less than 6 months
  • Patients who have received prior radiation therapy and who, in the opinion of the treating radiation oncologist, cannot be reirradiated safely without excess risk of severe toxicity given prior radiation dose to critical structures
  • Patients with known contraindications to radiotherapy, including inherited syndromes associated with hypersensitivity to ionizing radiation (e.g., Ataxia-Telangiectasia, Nijmegen Breakage Syndrome)
  • Female patients who are pregnant

About the trial

What the trial wants to find out

The purpose of this study is to examine the uses of a mobile health-based assessment and symptom monitoring platform.

The group in the trial

  • Ecological Momentary Assessments (EMAs)Other group

    Patients will receive one EMA (Ecologic Momentary Assessment) per day for approximately 75 days, through the provided smart phone application.

    Treatment: Ecologic Momentary Assessment (EMA)

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Quality of Life Assessment of Hypofractionated Radiotherapy in Recurrent Head and Neck Cancer: CPC-CT Pilot
Record updated
3 February 2026